Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 13 for transplant immunology

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients (IMAGINE)

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study to Evaluate the Effectiveness and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

    Rochester, MN

  3. An Open Label Follow-Up Study to Evaluate the Long Term Safety and Efficacy of L-CSA in Patients with a Diagnosis of CLAD-BOS after they have completed participation to BOSTON-1 and BOSTON-2 studies

    Jacksonville, FL

  4. Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients

    Rochester, MN

  5. Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas

    Rochester, MN

  6. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration

    Eau Claire, WI, Rochester, MN, Scottsdale/Phoenix, AZ

  7. A Study to Explore Ghrelin Levels with Primary Graft Dysfunction in Lung Transplant Recipients

    Jacksonville, FL

  8. A Study of Study of Immune Tolerance Mechanisms in Kidney Transplant Patients

    Scottsdale/Phoenix, AZ

  9. A Study to Assess the Updated Prospera™ Diagnostic Test

    Scottsdale/Phoenix, AZ

  10. A Study to Examine Diabetes Control and Patient Reported Outcomes Among Kidney Transplant Recipients with Type 2 Diabetes

    Rochester, MN

.

Mayo Clinic Footer